戻る Agenda
Student Session: Medical Risk Communication on Diabetes Medicine: What Information Should We Share?
Session Chair(s)
Mikako Einaga
Student, Department of Organic and Bioorganic Chemistry
Showa University, School of Pharmacy, Japan
Minami Mori
CRA, Clinical Operations
IQVIA Services Japan K.K., Japan
Toshiaki Suga
Pharmacy
Nihon University, Japan
Yuki Sugao
Tokyo University of Pharmacy and Life Science, Japan
No medication can be taken without any risk. Therefore, medical risk communication, the process of sharing medical risk information and of filling the gap of understanding of a medication between healthcare providers and others (especially patients) is an essential step not only for doctors but for everyone. This session stresses the importance of risk communication to future medical professionals by examining the SGLT2 inhibitor diabetes medicine. After the lecture segment of this session, participants will discuss in groups what risk information should be shared, with whom, and how.
Speaker(s)
Fundamentals and Practical Applications of Risk Communication on Medicines
Michiko Yamamoto, PhD
Kumamoto University, Japan
Visiting Professor
Student Session
Kasumi Daidoji, PhD, RPh
Eisai Co., Ltd., Japan
Associate Director, Clinical Planning & Development Dept., Medical Headquarters